Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vertex Pharmaceuticals (NQ: VRTX ) 501.45 +9.19 (+1.87%) Streaming Delayed Price Updated: 12:44 PM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Vertex Pharmaceuticals < Previous 1 2 3 4 5 6 7 8 9 ... 50 51 Next > Giving Uber Its Due February 15, 2024 We've also got a look at good news from Chipotle and Roblox, and we put some stocks on a dating show. Via The Motley Fool Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade. February 15, 2024 These stocks have what it takes to drive superior returns in the years to come. Via The Motley Fool Gene therapy: Why does it cost millions for a single treatment? February 15, 2024 Gene therapy treatments have been making major headlines as advances in gene editing have gone mainstream thanks to the advent of CRISPR/Cas-9 technology. Via MarketBeat Exposures Product Safety Is Vertex Pharmaceuticals Stock Too Expensive With a Price-to-Sales Ratio of 11x? February 15, 2024 There's more to consider with Vertex's valuation than one number. Via The Motley Fool Stock-Split Watch: Is Vertex Pharmaceuticals Next? February 14, 2024 It's on track to launch more blockbuster drugs. Via The Motley Fool Could Vertex Pharmaceuticals Reach $500 in 2024? February 10, 2024 Vertex shares have several catalysts on the horizon... Via The Motley Fool Vertex Pharmaceuticals Stock Is Approaching a Huge Catalyst, But Is It a Buy? February 08, 2024 Its pain medicine isn't precisely what it hoped for, but it could still sell. Via The Motley Fool $100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today February 07, 2024 Via Benzinga If You Invested $10,000 in Vertex Pharmaceuticals in 2014, This Is How Much You Would Have Today February 13, 2024 You can't go back in the past, but it's not too late to invest in this top stock. Via The Motley Fool European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia February 13, 2024 From Vertex Pharmaceuticals Incorporated Via Business Wire 2 Healthcare Stocks That Could Help Set You Up for Life February 12, 2024 These rock-solid businesses can add meaningful returns to a long-term portfolio. Via The Motley Fool 3 Groundbreaking Healthcare Stocks to Buy for Robust Gains February 11, 2024 Get the latest investment advice for healthcare stocks in 2024. Discover top picks and growth opportunities for the healthcare sector. Via InvestorPlace This High-Flying Stock Just Got Some Bad News: Should You Sell? February 06, 2024 It's just a minor setback for this leading biotech. Via The Motley Fool Vertex's Next-Gen Cystic Fibrosis Drug Scores Big; Shares Rise On Quarterly Beat February 05, 2024 The company also topped fourth-quarter expectations. Via Investor's Business Daily Is Vertex Pharmaceuticals Stock a Buy Now? February 10, 2024 The company just released its latest earnings report, and growth investors may be a little disappointed. Via The Motley Fool 2 Healthcare Stocks You Can Buy and Hold for the Next Decade February 10, 2024 These businesses are built to last. Via The Motley Fool 2 No-Brainer Healthcare Stocks to Buy Right Now February 10, 2024 Companies in the healthcare industry tend to generate returns in a wide range of market environments. Via The Motley Fool 3 Stocks That Could Trounce the Market in 2024 February 10, 2024 These stocks appear to have what it takes to beat the market this year. Via The Motley Fool 3 Growth Stocks With More Potential Than Any Cryptocurrency February 09, 2024 The stock market is full of opportunities for investors of all risk appetites and trading styles. Via The Motley Fool 3 Strong Buy Healthcare Stocks to Add to Your February Must-Watch List February 09, 2024 These strong buy healthcare stocks are among analysts' favorite picks, and their strong market position tells us why. Via InvestorPlace Stock Market Hits Highs As AI Plays Arm, Palantir Skyrocket: Weekly Review February 08, 2024 The S&P 500 hit 5,000. Arm, Palantir and Cloudflare rose sharply. Via Investor's Business Daily Topics Artificial Intelligence Stocks Exposures Artificial Intelligence US Equities Vertex's Next-Generation Cystic Fibrosis Program Shows Efficacy With Reduced Burden, Provides Growth Opportunity: Goldman Sachs February 06, 2024 Vertex Pharmaceuticals' cystic fibrosis treatment with vanza triple therapy. SKYLINE trials show non-inferiority to Trikafta, emphasizing once-daily dosing benefits. Via Benzinga Vertex Pharmaceuticals' Triple Combo Treatment For Lung Disorder Meets Primary Goal In Adult And Pediatric Patients February 06, 2024 Vertex Pharmaceuticals' vanza triple program for cystic fibrosis, with superior results in lung function, sweat chloride reduction, and safety. Via Benzinga Vertex Pharmaceuticals Has a $10 Billion Opportunity on the Table. Here's How You Can Invest February 06, 2024 Its foray into developing analgesics seems to be going swimmingly. Via The Motley Fool Uber To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday February 06, 2024 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Via Benzinga The 7 Best Healthcare Stocks to Invest In for Big Gains in 2024 February 06, 2024 Invest in the future with healthcare stocks 2024; offering a blend of market stability and cutting-edge medical advancements. Via InvestorPlace Vertex Pharmaceuticals (VRTX) Q4 2023 Earnings Call Transcript February 05, 2024 VRTX earnings call for the period ending December 31, 2023. Via The Motley Fool Topics Earnings Exposures Financial Vertex Reports Fourth Quarter and Full Year 2023 Financial Results February 05, 2024 From Vertex Pharmaceuticals Incorporated Via Business Wire Vertex Announces Positive Results From Pivotal Trials of Vanzacaftor/Tezacaftor/Deutivacaftor, Next-In-Class Triple Combination Treatment for Cystic Fibrosis February 05, 2024 From Vertex Pharmaceuticals Incorporated Via Business Wire Stocks Fall As Traders Dial Back Rate Cut Bets; Dollar, Treasury Yields Rise: What's Driving Markets Monday? February 05, 2024 Wall Street ends week on negative note as traders revise down expectations on Fed rate cuts. Strong economic data and Fed officials' comments push stocks into red, reducing rate cut expectations for... Via Benzinga Topics Economy Exposures Interest Rates < Previous 1 2 3 4 5 6 7 8 9 ... 50 51 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.